Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Asset disposition
Acq. announced
Director departure
Appointed director
|
|
MEDICINES CO (MDCO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/06/2020 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 01/06/2020 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Triggering Events That Accele...|
Docs:
|
"Amended and Restated Certificate of Incorporation of The Medicines Company",
"Amended and Restated Bylaws of The Medicines Company",
"Supplemental Indenture, to the indenture, between the Company and the Trustee",
"Supplemental Indenture, to the indenture, between the Company and the Trustee",
"Supplemental Indenture, to the indenture, between the Company and the Trustee",
"Notice of Redemption",
"The Medicines Company Announces Effective Date Of Make-Whole Fundamental Change Relating To Its 2.50% Convertible Senior Notes Due 2022, 2.75% Convertible Senior Notes due 2023 and 3.50% Convertible Senior Notes due 2024 PARSIPPANY, N.J., January 6, 2020 – The Medicines Company today provided notice of a Make-Whole Fundamental Change to holders of its 2.50% Convertible Senior Notes due 2022 , 2.75% Convertible Senior Notes due 2023 and 3.50% Convertible Senior Notes due 2024 . The consummation of the previously announced transactions contemplated by the Agreement and Plan of Merger, dated as of November 23, 2019 , by and among the Company, Novartis AG and Medusa Merger Corporation , constitutes a Make-Whole Fundamental Change under: the Indenture, dated as of January 13, 2015, governing th...",
"Fundamental Change Notice to Holders of 2.50% Convertible Senior Notes due 2022",
"Fundamental Change Notice to Holders of 2.75% Convertible Senior Notes due 2023" |
|
| 11/25/2019 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits Inte... |
| 10/30/2019 |
8-K
| Quarterly results |
| 07/24/2019 |
8-K
| Quarterly results |
| 06/28/2019 |
8-K
| Quarterly results |
| 06/05/2019 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 04/25/2019 |
8-K
| Quarterly results |
| 03/18/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/27/2019 |
8-K
| Quarterly results |
| 01/14/2019 |
8-K
| Asset disposition |
| 01/04/2019 |
8-K
| Asset disposition |
| 12/18/2018 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 12/14/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
| 12/12/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
| 12/12/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
| 12/11/2018 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits|
Docs:
|
"EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT , made this 10 th day of December 2018, is entered into by THE MEDICINES COMPANY, a Delaware corporation with its principal place of business at 8 Sylvan Way, Parsippany, New Jersey 07054 , and MARK TIMNEY . W I T N E S S E T H: WHEREAS, the Company desires to employ the Employee on the terms and subject to the conditions set forth in this Agreement, and the Employee desires to accept such employment. NOW, THEREFORE, for and in consideration of the premises and the mutual promises, covenants and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by the parties hereto, the parties agree as follows: Section 1.Term of Employment. The Company hereby agrees to emp...",
"on the Payment Date, in",
"The Medicines Company Appoints Mark Timney as Chief Executive Officer" |
|
| 11/08/2018 |
8-K
| Quarterly results |
| 08/28/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/01/2018 |
8-K
| Quarterly results |
| 06/06/2018 |
8-K
| Quarterly results |
| 04/25/2018 |
8-K
| Quarterly results |
| 03/27/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/27/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/26/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/21/2018 |
8-K
| Quarterly results |
| 02/06/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/11/2018 |
8-K
| Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits |
| 01/05/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/04/2017 |
8-K
| Entry into a Material Definitive Agreement, Cost Associated with Exit or Disposal Activities, Other Events, Financial Stateme... |
| 11/15/2017 |
8-K
| Appointed a new director |
| 10/25/2017 |
8-K
| Quarterly results |
| 10/20/2017 |
8-K/A
| Submission of Matters to a Vote of Security Holders |
| 08/09/2017 |
8-K
| Quarterly results |
|
|
|